ProFound AI Risk, a diagnostic tool that estimates the risk of breast cancer over a two-year period following a mammogram, has received a CE mark from the European Commission. The CE mark is a certification for products sold in the European Economic Area to indicate the product has met all legal standards, and has been evaluated to meet all safety, health, and environmental regulations. “The CE Marking of this technology is a significant milestone that represents the…
You must be logged in to read/download the full post.
The post EU Certifies Software That Assesses Short-term Breast Cancer Risk appeared first on BioNewsFeeds.